Category: Latest News

The Multiple Sclerosis Association of America (MSAA) is pleased to announce that we are the recipients of a Fall 2024 Digital Health Award! We are proud to have been presented with a Silver Digital Health Award in the Web-based Digital Health category for MSAA’s 2024-2025 Art Showcase. For several years, MSAA has highlighted the inspiring artwork and stories of artists with multiple sclerosis from across the country.

From expanded treatment options and encouraging results from clinical trials of investigational therapies, to important information on MS, oral contraceptive use, and cardiovascular health, this edition of “What’s New in MS Research” reflects the extent and breadth of efforts to better treat multiple sclerosis and to enhance the overall health of people living with the condition.

It wasn’t just the music that had multiple sclerosis (MS) researchers, clinicians, and advocates in an upbeat mood when they gathered in Nashville from May 29th through June 1st for the Consortium of Multiple Sclerosis Centers’ (CMSC) 2024 Annual Meeting. Rather, the positive vibes reflected the many encouraging developments in MS research reported during the CMSC’s multi-day gathering.

The Multiple Sclerosis Association of America (MSAA) is proud to announce that we are the recipients of an APEX Award for Excellence from the 36th Annual APEX Awards, as well as a Merit Award from the 31st Annual National Health Information Awards!

The Multiple Sclerosis Association of America (MSAA) is proud to recognize 15 years of our inspiring and interactive online Art Showcase. Each year, MSAA hosts the Art Showcase, encouraging individuals with multiple sclerosis to create and submit works of art along with their personal stories to be shared with the community.

The Multiple Sclerosis Association of America (MSAA) is pleased to announce that we are the recipients of three awards from the 26th annual Digital Health Awards®! Organized by the Health Information Resource Center (HIRC), the Digital Health Awards recognize leading digital health resources developed for consumers and health professionals. Award entries are evaluated by type of content, format, targeted consumer audience, and overall quality.

The astounding breadth of research being conducting into the causes, manifestations, and management of multiple sclerosis (MS) was on full display when thousands of physicians, nurses, laboratory scientists, and others gathered in Denver in April for the annual meeting of the American Academy of Neurology (AAN).

The Multiple Sclerosis Association of America (MSAA) and Novartis Pharmaceuticals Corporation have collaborated to develop the Multiple Sclerosis Implementation Network™ (MSIN™). This is an exciting and unique initiative to create a practice-based research network (PBRN) for medical professionals to best support individuals with MS.  MSIN is a patient-centric initiative, emphasizing the vital role of people living with MS and their involvement in this practice-based research network. MSIN will be guided by two advisory boards – one of which will be comprised of people living with MS and their care partners. The other advisory board will be comprised of healthcare professionals, research scientists, and advocacy partners.

The Multiple Sclerosis Association of America (MSAA) is excited to invite members of the MS community to our 10th Improving Lives Benefit on Wednesday, May 15, 2024, at 6:30 pm ET, at the Barnes Foundation in Philadelphia, PA. This event will also be livestreamed, allowing individuals from across the country to participate from the comfort of their homes. Those attending will have the opportunity to connect with inspiring individuals, recognize our special honorees, and support MSAA’s programs and services that are provided at no cost to the MS community.

From February 29th through March 2nd of this year, MS researchers and clinicians gathered in West Palm Beach for the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2024. These healthcare professionals came not only to ask questions but also to provide answers obtained from recent studies addressing varied facets of multiple sclerosis.